Shoichi Hazama

Tokuyama (Japan) — Japan

Medicine · Health Sciences

50h-index10.9kcitations350works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(76), Colorectal Cancer Treatments and Studies(67), Immunotherapy and Immune Responses(64), Gastric Cancer Management and Outcomes(30), Hepatocellular Carcinoma Treatment and Prognosis(26)

Publications348 total

[A Case of Conversion Surgery after SOX+Nivolumab Treatment for Metastatic Gastric Cancer].
PubMed·2025
[A Case of Cecal‒Ascending Colon Cancer Achieved Complete Remission by Surgical Resection and Immune Checkpoint Inhibitor].
PubMed·2025
[A Case of MSI‒Stable Rectal Cancer with Para‒Aortic Lymph Node Metastasis Treated by Sequential Therapy with Standard Treatment and Immune Checkpoint Inhibitors].
PubMed·2025
Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor Mutation Burden, Stages, and Metastasis
Anticancer Research·2025
A Case of Inflammatory Myofibroblastic Tumor in the Abdominal Wall with Anaplastic Lymphoma Kinase and Whole Exome Sequencing Analysis
Surgical Case Reports·2025Open Access
Novel Artificial Intelligence Combining Convolutional Neural Network and Support Vector Machine to Predict Colorectal Cancer Prognosis and Mutational Signatures From Hematoxylin and Eosin Images
Modern Pathology·2024· 11 cited
Rectal squamous cell carcinoma treated with neoadjuvant fluorouracil, oxaliplatin, cetuximab, and radiation: A case report of pathological complete response
Medicine·2024Open Access
Right-sided versus left-sided colorectal cancer in elderly patients: a sub-analysis of a large multicenter case–control study in Japan
Surgery Today·2024· 6 citedOpen Access
High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancer
BMC Cancer·2024· 8 citedOpen Access
Serum proteinase-3 levels as a predictor of progression-free survival of first-line chemotherapy in metastatic colorectal cancer
Research Square (Research Square)·2023Open Access
[A Recurrent Colon Cancer Successfully Treated by Nivolumab plus Ipilimumab with On and Off for Preventing Exacerbation of Skin Disorders].
PubMed·2023
IL-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer
Annals of Surgical Oncology·2023· 23 cited
ASO Visual Abstract: Interleukin-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer
Annals of Surgical Oncology·2023
Data from Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis
2023Open Access
Supplementary information from Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis
2023Open Access
Supplementary information from Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis
2023Open Access
Data from Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis
2023Open Access
Juvenile colon cancer diagnosed by onset of intussusception: a case report suggestive of Lynch syndrome treated with laparoscopic colectomy
Research Square (Research Square)·2023Open Access
Supplementary Figures 1-3, Table 1 from Integrin α2 Mediates Selective Metastasis to the Liver
2023Open Access
Supplementary Figure Legends 1-3, Table Legend from Integrin α2 Mediates Selective Metastasis to the Liver
2023Open Access
page 1 of 18Next →

Frequent Co-authors

Masaaki Oka(23), Shigefumi Yoshino(17), Nobuaki Suzuki(16), Ryouichi Tsunedomi(13), Yutaka Suehiro(11), Yoshitaro Shindo(11), Yuji Hinoda(10), Tomio Ueno(9), Kiyoshi Yoshimura(9), Hiroaki Nagano(7), Michihisa Iida(7), Hiroko Takenouchi(7), Hiroaki Nagano(7), Kiyotaka Okuno(6), Toshihiko Torigoe(5), Norio Iizuka(5), Akira Tangoku(5), M. Nishioka(5), Naoko Okayama(5), Hiroto Matsui(5)